Gene Therapy May Be Long-Term Cure for Type of Hemophilia
THURSDAY, Jan. 2, 2020 -- A new gene therapy appears to serve as a functional cure for the most common type of hemophilia, early clinical trial results indicate.
Patients who received the one-time intravenous therapy continue to have a more than... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 2, 2020 Category: General Medicine Source Type: news
Two IV therapy businesses coming to Milwaukee's 3rd Ward
Two businesses that provide intravenous hydration services are adding locations to the 3rd Ward neighborhood in Milwaukee.
One business, H2O Health Hydration Oasis, opened its first location in Brookfield. Dr. Alia Fox founded the health and wellness clinic, which offers custom IV therapy. H2O promotes its services as “IV therapy cocktails.”
The company markets its “cocktails” as a solution for viral illness es, fatigue, wound healing and hangovers, among other uses. Fox said although IV… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 19, 2019 Category: Pharmaceuticals Authors: Sari Lesk Source Type: news
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
RCT (n=1054) found oral antibiotic therapy non-inferior to IV therapy when used during first 6 weeks in treatment for bone/joint infection, as assessed by definitive treatment failure within 1 year of randomisation (14.62% IV vs 13.16% oral), challenging current standard of care (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 27, 2019 Category: Consumer Health News Source Type: news
NIHR Signal: Iron deficiency in people with chronic kidney disease can be managed with either oral or IV therapy
Expert commentary is provided for a review of 39 RCTs (n=3,852) which found that death and cardiovascular death rates were not different for IV and oral iron. Questions remain about cost-effectiveness and tolerability of both oral and IV therapies. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 6, 2019 Category: Consumer Health News Source Type: news
'Stem cell' therapies offered at private clinics need to be approved as drugs, Health Canada says
Across Canada, private clinics charge thousands of dollars for injections and IV therapies using what they claim are stem cells. This week, Health Canada ruled that those cell therapies are drugs that must be approved. But so far, the agency has not ordered clinics to stop doing the procedures. (Source: CBC | Health)
Source: CBC | Health - May 18, 2019 Category: Consumer Health News Tags: News/Health Source Type: news
Switching to oral antibiotics early for bone and joint infections gave similar results to continuing intravenous therapy
This research provides good evidence that bone and joint infections can be treated with predominantly oral regimens. This could have several benefits, not least the greater freedom afforded to patients and reduced costs.The importance of taking the medication and potential treatment side effects need to be explained so that patients can seek medical support to modify the treatment when necessary. Also, staff perceptions surrounding the effectiveness of oral antibiotics for this indication also need to be addressed to enable a shift in practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 25, 2019 Category: Consumer Health News Source Type: news
Giving intravenous therapy to children at home is costly, lowers parents' quality of life
(University of Utah Health) When treating patients, doctors sometimes overlook how their decisions impact a world they never see: a patient's home life. In the case of some serious infections in children, oral antimicrobial drugs are just as good at treating these ailments at home as the standard, intravenous medications. But according to new research led by investigators at University of Utah Health, by-mouth medications excel in the important measure of preserving parents' quality of life. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 25, 2019 Category: Infectious Diseases Source Type: news
Clinical Nurse Specialist- Endocrinology
Vacancies for Band 7 Senior Clinical Nurse Specialists in Endocrinology (QEHB and HGS) at University Hospitals Birmingham NHS Foundation Trust.Salary:£33,222-£43,041Interview date expected to be10 April 2019Two exciting opportunities have arisen for individuals to contribute towards the provision of excellent patient care within our Endocrinology and Diabetes Service. We are looking to appointment two Senior Clinical Nurse Specialists in Endocrinology. One post will be for our Heartlands, Good Hope and Solihull Hospital site (HGS) and the other for our Queen Elizabeth Hospital Birmingham(QEHB) ...
Source: Society for Endocrinology - March 18, 2019 Category: Endocrinology Source Type: news
Celebrities help the £500 vitamin jab go mainstream
Intravenous therapy has taken off via social media after star names led the way. But its effects are unknown, doctors warnMadonna does it. Rihanna ’s done it. Katy Perry, Rita Ora and Gwyneth Paltrow have been known to dabble and while there are no clinical studies to prove the benefits of intravenous vitamin therapy, the celebrity wellness trend appears to have gone fully mass market.In a gleaming west London clinic, with plump leather recliners and a TV tuned to Netflix, Yassine Bendiabdallah explains the benefits of his IV treatments. Customers, mostly wealthy and mostly women, visit him for courses of injections prom...
Source: Guardian Unlimited Science - March 3, 2019 Category: Science Authors: Nosheen Iqbal Tags: Health & wellbeing Nutrition Science UK news Society Source Type: news
FDA: West Pharma recall of Vial2Bag fluid transfer systems is Class I
The FDA recently labeled a select recall of West Pharmaceutical Services‘ (NYSE:WST) Vial2Bag fluid transfer systems over device functionality issues as Class I.
Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences of death.
The West Whiteland Township, Penn.-based company’s Vial2Bag fluid transfer systems are designed to connect a vial containing medication to an intravenous therapy bag to aid in mixing the medication with the IV fluids, according to an FDA release.
Read the whole story on our sister site, D...
Source: Mass Device - February 4, 2019 Category: Medical Devices Authors: Fink Densford Tags: Drug Pumps Featured Food & Drug Administration (FDA) Recalls West Pharmaceutical Services Inc. Source Type: news
Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia
This journal article covering a cohort study (n=2,161) found no mortality difference with oral step down within 5 days vs continued IV antibiotics (13.1% vs 13.4%, p>0.05). There was also no difference in bacteraemia recurrence, and patients given step down treatment were discharge on average 2 days sooner. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 24, 2019 Category: Consumer Health News Source Type: news
Is IV therapy a 2019 wellness trend you need to try?
IV clinics are popping up in cities and towns across the country. (Source: ABC News: Health)
Source: ABC News: Health - January 15, 2019 Category: Consumer Health News Tags: GMA Source Type: news
State takes action against physician, chiropractor involved with Overland Park IV clinic
The Kansas Board of Healing Arts has issued orders restricting an area physician and chiropractor from practicing in an Overland Park IV clinic.
The board issued emergency orders temporarily restricting Dr. Angela Garner and chiropractor Tara Zeller from practicing with IV Nutrition Clinic or any substantially similar IV therapy clinic until further licensing hearings can be held. Brian Niceswanger, an Evans& Dixon LLC lawyer representing Garner and Zeller, said the two have a hearing scheduled … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 31, 2018 Category: Pharmaceuticals Source Type: news
Applying Quality Management Best Practices for Medtech
Conclusion
Today's medical device manufacturers are in a race every day to improve compliance, quality, and production scale and speed so they can retain customers and win new ones. Being able to simultaneously compete across these conflicting dimensions of their business makes real-time monitoring essential for providing an accurate, continual data stream that powers analytics and BI applications for insights into improvement. Compliance and quality require exceptional data accuracy and precision to generate the reports and ongoing regulatory filings essential for selling into various countries and industries around the w...
Source: MDDI - October 17, 2018 Category: Medical Devices Authors: Anthony Parise and Louis Columbus Tags: Regulatory and Compliance Source Type: news
ivWatch Finds Strong Ally in Philips to Monitor Peripheral IVs
When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure that has a startling 50% fail rate. ivWatch, the only provider of continuous non-invasive monitoring devices that can detect IV infiltrations and extravasations, hopes to curb those numbers after announcing that their devices will now be compatible with Philips Intellivue Patient Monitors.
“For too long IV infiltration has been an accepted outcome of peripheral intravenous therapy,” says Gary Warren, president and CEO o...
Source: MDDI - July 5, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: IV Products Source Type: news
